phenylalanine has been researched along with Ovarian Neoplasms in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (36.00) | 18.7374 |
| 1990's | 8 (32.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bronich, TK; Cohen, SM; Desale, SS; Kabanov, AV; Zhao, Y | 1 |
| Bronich, TK; Desale, S; Kabanov, AV; Kim, JO; Oberoi, HS | 1 |
| Castellano, F; Mestivier, D; Molinier-Frenkel, V | 1 |
| Carlier, C; Ceelen, WP; De Vlieghere, E; Gullbo, J; Juntti, T; Larsson, R; Lewensohn, R; Nygren, P; Spira, J; Strese, S; Uustalu, M; Velander, E; Viktorsson, K | 1 |
| Fuchs, D; Grahmann, AV; Klieber, M; Ledochowski, M; Neurauter, G; Sperner-Unterweger, B; Zeimet, A | 1 |
| CHEBOTAREVA, LI | 1 |
| BELOUSOVA, AK; IVANOVA, TJ | 1 |
| Belotti, D; Garofalo, A; Giavazzi, R; Manenti, L; Marchini, S; Paganoni, P; Taraboletti, G | 1 |
| Arrastia, CD; Casperson, SL; Dillon, EL; Paddon-Jones, D; Sanford, AP; Sheffield-Moore, M; Sinha, S; Urban, RJ; Volpi, E; Wolfe, RR | 1 |
| Balasubramanian, R; Fecik, RA; Raghavan, B; Sackett, DL; Steele, JC | 1 |
| Doellgast, GJ; Homesley, HD | 1 |
| Brown, PD | 2 |
| Balkwill, FR; Brown, PD; Crimmin, MJ; Davies, B; East, N | 1 |
| Page, M; Perron, MJ | 1 |
| McCann, PP; Rasmussen, HS | 1 |
| Balkwill, FR; Burke, F; East, N; Patel, K; Upton, C | 1 |
| Bone, EA; Brown, PD; Chiari, S; Ferri, C; Garofalo, A; Giavazzi, R; Lucchini, V; Nicoletti, MI; Taraboletti, G | 1 |
| Bassano, L; D'Incalci, M; Erba, E; Giavazzi, R; Ronzoni, S | 1 |
| Kotova, DG; Razgovorova, ZK | 1 |
| Brandt, MB; Kuttner, RE; Lorincz, AB | 1 |
| Brecher, AS; König, M; Pugatch, RD; Sobel, RE; Suszkiw, JB; Wasilauskas, VP | 1 |
| Jorgensen, EO; Malkasian, GD; Webb, MJ | 1 |
| Fishman, WH; Sasaki, M | 1 |
| Karuzina, NP; Timofeevskaia, EA | 1 |
2 review(s) available for phenylalanine and Ovarian Neoplasms
| Article | Year |
|---|---|
Clinical trials of a low molecular weight matrix metalloproteinase inhibitor in cancer.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Colorectal Neoplasms; Female; Humans; Metalloendopeptidases; Mice; Mice, Nude; Ovarian Neoplasms; Phenylalanine; Thiophenes; Transplantation, Heterologous | 1994 |
Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Colorectal Neoplasms; Enzyme Inhibitors; Female; Hemangioma; Humans; Hydroxamic Acids; Melanoma; Metalloendopeptidases; Mice; Ovarian Neoplasms; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Skin Neoplasms; Thiophenes | 1997 |
23 other study(ies) available for phenylalanine and Ovarian Neoplasms
| Article | Year |
|---|---|
Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cisplatin; Delayed-Action Preparations; Female; Glutamic Acid; Humans; Mice; Mice, Nude; Micelles; Ovarian Neoplasms; Ovary; Paclitaxel; Phenylalanine; Polyethylene Glycols | 2013 |
Polypeptide nanogels with hydrophobic moieties in the cross-linked ionic cores: synthesis, characterization and implications for anticancer drug delivery.
Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Cross-Linking Reagents; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Gels; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Mice; Nanoparticles; Ovarian Neoplasms; Particle Size; Phenylalanine; Polyethylene Glycols; Polyglutamic Acid; Polymers; Time Factors; Xenograft Model Antitumor Assays | 2013 |
Alterations of the immunosuppressive IL4I1 enzyme activity induced by naturally occurring SNP/mutations.
Topics: Animals; Arginine; Exons; Female; Gene Expression; HEK293 Cells; Humans; Introns; L-Amino Acid Oxidase; Monoamine Oxidase; Mutation; Ovarian Neoplasms; Phenylalanine; Polymorphism, Single Nucleotide; Protein Structure, Quaternary; Recombinant Proteins; Structural Homology, Protein; Tumor Escape; Viperidae | 2016 |
Preclinical activity of melflufen (J1) in ovarian cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cytoreduction Surgical Procedures; Disease-Free Survival; Drug Evaluation, Preclinical; Female; Humans; Hyperthermia, Induced; Injections, Intraperitoneal; Melphalan; Mice; Mice, SCID; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Phenylalanine; Xenograft Model Antitumor Assays | 2016 |
Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8.
Topics: Biomarkers; Biomarkers, Tumor; Cystadenocarcinoma; Endometrial Neoplasms; Female; HIV Infections; Humans; Isoprostanes; Lymphocyte Activation; Neoplasm Staging; Neopterin; Ovarian Neoplasms; Oxidative Stress; Phenylalanine; Receptors, Tumor Necrosis Factor, Type II; Sepsis; Tyrosine; Uterine Neoplasms | 2008 |
[Experience in treating seminoma of the testes and its metastases with sarcolysin].
Topics: Dysgerminoma; Female; Humans; Male; Melphalan; Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Phenylalanine; Seminoma; Testicular Neoplasms; Testis | 1956 |
ON THE MECHANISM OF SARCOLYSIN FIXATION BY PROTEINS OF TUMOUR CELLS.
Topics: Animals; Autoradiography; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Chloramphenicol; Culture Media; DNA; DNA, Neoplasm; Female; Humans; Melphalan; Ovarian Neoplasms; Pharmacology; Phenylalanine; Proteins; Research; RNA; RNA, Neoplasm; Sarcoma; Sarcoma, Experimental | 1964 |
Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation.
Topics: Animals; Ascites; Cell Movement; Culture Media, Conditioned; Endothelial Growth Factors; Enzyme Activation; Female; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Nude; Ovarian Neoplasms; Peritoneal Cavity; Phenylalanine; Thiophenes; Transplantation, Heterologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Amino acid metabolism and inflammatory burden in ovarian cancer patients undergoing intense oncological therapy.
Topics: Amino Acids; Blood Chemical Analysis; Cytokines; Deuterium; Female; Humans; Inflammation; Middle Aged; Muscle Proteins; NF-kappa B; Ovarian Neoplasms; Phenylalanine | 2007 |
Tubulysin analogs incorporating desmethyl and dimethyl tubuphenylalanine derivatives.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Female; Humans; Inhibitory Concentration 50; Models, Chemical; Oligopeptides; Ovarian Neoplasms; Phenylalanine; Stilbenes; Structure-Activity Relationship; Tubulin Modulators | 2008 |
Placental-type alkaline phosphatase in ovarian cancer fluids and tissues.
Topics: Alkaline Phosphatase; Ascitic Fluid; Female; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Phenylalanine; Placenta | 1984 |
Matrix metalloproteinase inhibitors: a novel class of anticancer agents.
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Female; Humans; Melanoma, Experimental; Metalloendopeptidases; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Phenylalanine; Protease Inhibitors; Thiophenes | 1995 |
A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts.
Topics: Aged; Animals; Carcinoma; Cell Division; Extracellular Matrix; Female; Humans; In Vitro Techniques; Metalloendopeptidases; Mice; Molecular Structure; Neoplasm Transplantation; Ovarian Neoplasms; Phenylalanine; Survival Analysis; Thiophenes; Transplantation, Heterologous; Tumor Cells, Cultured | 1993 |
Activation of methotrexate-phenylalanine by monoclonal antibody--carboxypeptidase A conjugate for the specific treatment of ovarian cancer in vitro.
Topics: Antibodies, Monoclonal; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Carboxypeptidases; Carboxypeptidases A; Female; Humans; Methotrexate; Ovarian Neoplasms; Phenylalanine; Prodrugs; Tumor Cells, Cultured | 1996 |
Interferon gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: enhancement of effect by batimastat.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cystadenocarcinoma, Serous; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Interferon-gamma; Metalloendopeptidases; Mice; Mice, Nude; Ovarian Neoplasms; Phenylalanine; Survival Rate; Thiophenes; Transplantation, Heterologous; Tumor Suppressor Protein p53 | 1997 |
Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cisplatin; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Female; Humans; Metalloendopeptidases; Mice; Mice, Nude; Ovarian Neoplasms; Phenylalanine; Protease Inhibitors; Survival Analysis; Thiophenes; Transplantation, Heterologous | 1998 |
The metalloproteinase inhibitor batimastat (BB-94) causes cell cycle phase perturbations in ovarian cancer cells.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Female; Humans; Metalloendopeptidases; Ovarian Neoplasms; Phenylalanine; Protease Inhibitors; Thiophenes | 1999 |
[Use of lophenal in patients with malignant ovarian tumors].
Topics: Antineoplastic Agents; Female; Humans; Nitrogen Mustard Compounds; Ovarian Neoplasms; Phenylalanine | 1976 |
Tumor response to phenylalanine-tyrosine-limited diets.
Topics: Adenocarcinoma; Amino Acids; Animals; Carcinoma, Hepatocellular; Cystadenoma; Deficiency Diseases; Diet Therapy; Female; Humans; Liver Neoplasms; Mammary Neoplasms, Experimental; Mice; Middle Aged; Neoplasms, Experimental; Ovarian Neoplasms; Phenylalanine; Sarcoma, Experimental; Tyrosine | 1969 |
The hydrolytic activity in normal human and malignant tissue.
Topics: Acid Phosphatase; Adenocarcinoma, Papillary; Alanine; Alkaline Phosphatase; Amides; Amidohydrolases; Arginine; Brain; Carcinoma, Intraductal, Noninfiltrating; Cecal Neoplasms; Cobalt; Dipeptidases; Female; Glioma; Humans; Leucine; Manganese; Naphthalenes; Ovarian Neoplasms; Peptide Hydrolases; Phenylalanine | 1969 |
Observations on chemotherapy of granulosa cell carcinomas and malignant ovarian teratomas.
Topics: Adolescent; Adult; Antineoplastic Agents; Castration; Child; Cyclophosphamide; Dactinomycin; Fallopian Tubes; Female; Fluorouracil; Granulosa Cell Tumor; Humans; Hysterectomy; Middle Aged; Ovarian Neoplasms; Phenylalanine; Pregnancy; Teratoma; Vincristine | 1974 |
Ultrastructural studies on Regan and non-Regan isoenzymes of alkaline phosphatase in human ovarian cancer cells.
Topics: Alkaline Phosphatase; Aminocaproates; Cell Membrane; Cell Nucleus; Endoplasmic Reticulum; Female; Golgi Apparatus; Guanidines; Histocytochemistry; Histological Techniques; Humans; Isoenzymes; Microscopy, Electron; Mitochondria; Ovarian Neoplasms; Phenylalanine | 1973 |
[The effect of thio-TEPA on the incorporation of labeled precursors into DNA and protein of human neoplastic cells in tissue culture].
Topics: Carbon Isotopes; Culture Techniques; DNA, Neoplasm; Female; Humans; Neoplasm Proteins; Ovarian Neoplasms; Pancreatic Neoplasms; Phenylalanine; Stomach Neoplasms; Thiotepa; Thymidine | 1968 |